Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Delta hepatitis virus infection in Ethiopia.

Literature DB >> 3402577

Delta hepatitis virus infection in Ethiopia.

M Rapicetta¹, K Hailu, A Ponzetto, C Hele, G Morace, D Bekura, L Bisanti, S Conti, P Pasquini, M Rizzetto.

Abstract

The results of Hepatitis Delta virus (HDV) antibody determinations carried on 566 HBsAg positive serum samples from a population of 5270 Ethiopian military recruits are reported. The prevalence of anti-HDV among apparently healthy HBsAg carriers was 5.8%. The prevalence increases with age within the available range (18-30 years). Differences might exist by area of origin and ethnic groups. The distributions of HBV markers was similar in anti HDV positive and anti HDV negative individuals, possibly due to the relatively young age of the population and/or the hyperendemic condition of the area.

Entities: Disease Species

Mesh：

Substances：

Year: 1988 PMID： 3402577 DOI： 10.1007/bf00144749

Source DB: PubMed Journal: Eur J Epidemiol ISSN： 0393-2990 Impact factor: 8.082

9 in total

1. Frequency of delta agent infections in Kuwait.

Authors: E Nordenfelt; B G Hansson; B Al-Nakib; S Al-Kandari; W Al-Nakib
Journal: J Infect Dis Date: 1983-10 Impact factor: 5.226

2. Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay.

Authors: G Morace; K von der Helm; W Jilg; F Deinhardt
Journal: J Virol Methods Date: 1985-12 Impact factor: 2.014

3. A note on prevalence of anti-delta antibodies in a sample of 5005 healthy individuals.

Authors: P Pasquini; P Dentico; A Panà; I Terzi
Journal: Boll Ist Sieroter Milan Date: 1985

4. Epidemic hepatitis B with delta-antigenaemia among Dublin drug-abusers.

Authors: A G Shattock; M G Kelly; J Fielding; Y Arthurs
Journal: Ir J Med Sci Date: 1982-11 Impact factor: 1.568

5. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.

Authors: S Arico; M Aragona; M Rizzetto; F Caredda; A Zanetti; G Marinucci; S Diana; P Farci; M Arnone; N Caporaso
Journal: Lancet Date: 1985-08-17 Impact factor: 79.321

6. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors: G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal: Lancet Date: 1982-01-30 Impact factor: 79.321

7. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.

Authors: J Goudsmit; F van der Waals; A Ponzetto; B Forzani; C Dobbelaar
Journal: J Trop Med Hyg Date: 1984-12

8. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.

Authors: A Smedile; C Lavarini; P Farci; S Aricò; G Marinucci; P Dentico; G Giuliani; A Cargnel; C Del Vecchio Blanco; M Rizzetto
Journal: Am J Epidemiol Date: 1983-02 Impact factor: 4.897

9. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen.

Authors: M Rizzetto; J W Shih; J L Gerin
Journal: J Immunol Date: 1980-07 Impact factor: 5.422

9 in total

4 in total